Roche Holding AG
(Swiss Exchange : RHHBF)

( )
RHHBF After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 3.32%133.080.7%$2112.60m
PFEPfizer Inc. 3.53%32.870.9%$1387.47m
MRKMerck & Co., Inc. 4.12%76.840.7%$1300.89m
ABBVAbbVie, Inc. 2.37%75.162.3%$1236.30m
BMYBristol-Myers Squibb Co. 1.47%55.171.0%$1077.97m
LLYEli Lilly & Co. 4.20%142.151.1%$915.90m
NVSNovartis AG 3.25%83.560.2%$310.08m
AZNAstraZeneca Plc -0.11%43.731.2%$290.86m
GSKGlaxoSmithKline Plc 1.34%37.720.2%$255.80m
FTSVForty Seven, Inc. -0.01%95.430.0%$186.11m
NVONovo Nordisk A/S -0.74%59.310.1%$171.16m
SNYSanofi 1.40%43.510.2%$159.05m
BHCBausch Health Cos., Inc. -1.31%13.570.0%$88.68m
RARXRa Pharmaceuticals, Inc. -0.03%48.000.8%$82.28m
RGENRepligen Corp. 2.78%96.957.1%$73.08m

Company Profile

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.